NASDAQ:ANAB

AnaptysBio Insider Trades

$22.01
+0.10 (+0.46 %)
(As of 04/21/2021 01:50 PM ET)
Add
Compare
Today's Range
$21.56
Now: $22.01
$22.27
50-Day Range
$19.00
MA: $22.36
$29.47
52-Week Range
$13.92
Now: $22.01
$35.85
Volume3,683 shs
Average Volume522,443 shs
Market Capitalization$602.33 million
P/E RatioN/A
Dividend YieldN/A
Beta0.15

Insider Trades

AnaptysBio (NASDAQ:ANAB) Insider Buying and Selling Activity

Insider Ownership Percentage: 13.00%
Insider Buying (Last 12 Months): $53,446,526.00
Insider Selling (Last 12 Months): $350,000.00

Insider Buying and Selling by Quarter


AnaptysBio (NASDAQ ANAB) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/8/2021Ecor1 Capital, LlcMajor ShareholderBuy2,777,800$18.97$52,694,866.00  
2/23/2021Ecor1 Capital, LlcMajor ShareholderBuy29,500$25.48$751,660.00  
2/12/2021Eric J LoumeauCOOSell10,000$35.00$350,000.0010,000  
6/10/2019Hamza SuriaCEOSell22,428$73.76$1,654,289.2831,524  
6/4/2019Marco LondeiInsiderSell10,060$73.06$734,983.6032,437  
1/15/2019Marco LondeiInsiderSell19,075$69.88$1,332,961.0022,377  
1/14/2019Hamza SuriaCEOSell40,000$70.79$2,831,600.0070,064  
12/17/2018Marco LondeiInsiderSell30,048$66.76$2,006,004.48152,925  
12/14/2018Hamza SuriaCEOSell41,728$69.36$2,894,254.0871,792  
12/12/2018Hamza SuriaCEOSell65,585$71.47$4,687,359.9565,649  
12/10/2018Hamza SuriaCEOSell30,587$71.19$2,177,488.5365,649  
12/3/2018Dominic PiscitelliCFOSell37,000$72.14$2,669,180.0037,000  
4/16/2018Nicholas LydonDirectorSell33,000$86.88$2,867,040.00301,506  
8/21/2017Holdings A/S NovoMajor ShareholderSell356,300$21.10$7,517,930.001,936,604  
8/15/2017Holdings A/S NovoMajor ShareholderSell178,600$21.16$3,779,176.002,436,332  
8/7/2017Holdings A/S NovoMajor ShareholderSell491,294$21.12$10,376,129.282,952,527  
8/3/2017Holdings A/S NovoMajor ShareholderSell70,706$23.31$1,648,156.863,009,949  
7/26/2017Ventures Vii L P AvalonMajor ShareholderSell37,040$24.35$901,924.00  
1/31/2017Healthcare Vii L.P. FrazierMajor ShareholderBuy400,000$15.00$6,000,000.00  
1/31/2017Nicholas LydonDirectorBuy16,666$15.00$249,990.00270,957  
(Data available from 1/1/2013 forward)
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.